Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 2015Annales de biologie clinique

Contribution of the collagen binding activity (VWF:CB) in the range of tests for the diagnosis and classification of von Willebrand disease

View Full Paper
Ask AI
Bookmark
Share

Key result

The VWF:CB test showed good correlation with VWF:RCo for all VWD types except type 2 and good concordance with multimer pattern, serving as an alternative for diagnosing quantitative VWF deficiencies.

Why the study?

Does the VWF collagen binding test (VWF:CB) improve the diagnosis and classification of von Willebrand disease compared to VWF:RCo and multimer pattern in patients with recurrent bleeding?

Population

19 patients suffering from recurrent bleeding

Comparison

von Willebrand factor collagen binding test vs VWF risticetin cofactor activity and multimer…

Design

Cross-sectional

Authors

MFMeriem Yasmine Ferhat-HamidaCentre Hospitalo-Universitaire Bab El OuedHBHouda BoukerbCentre Hospitalo-Universitaire Bab El OuedGHGhania HaritiCentre de Recherche Nucléaire d’Alger

Discussion

Loading...

Member takes

Implication

Supports VWF:CB as alternative for quantitative VWD diagnosis; leaves open utility in type 2 and routine classification.

Study Design

Type

Observational (n=19)

Structured PICO

Does the VWF collagen binding test (VWF:CB) improve the diagnosis and classification of von Willebrand disease compared to VWF:RCo and multimer pattern in patients with recurrent bleeding?

P
Population
19 patients suffering from recurrent bleeding evaluated to diagnose and classify von Willebrand disease subtypes.
E
Exposure
von Willebrand factor (VWF) collagen binding test (VWF:CB)
C
Comparator
VWF risticetin cofactor (VWF:RCo) activity and multimer pattern
O
Outcome
Diagnosis and classification of VWD subtypessurrogate

VWF:CB is a viable alternative to VWF:RCo and multimer pattern for diagnosing quantitative VWF deficiencies, though it does not replace qualitative defect testing.

Limitations

  • VWF:CB did not help in diagnosing the 'uncertain type 1' group and cannot replace testing for qualitative defects

Cite This Study

Ferhat-Hamida et al. (2015) conducted an observational in von Willebrand disease (n=19). von Willebrand factor collagen binding test (VWF:CB) vs. VWF risticetin cofactor (VWF:RCo) and multimer pattern was evaluated on Diagnosis and classification of VWD subtypes. The VWF:CB test showed good correlation with VWF:RCo for all VWD types except type 2 and good concordance with multimer pattern, serving as an alternative for diagnosing quantitative VWF deficiencies.

synapsesocial.com/papers/6a99b7e2e3aba222d6e2768dhttps://doi.org/10.1684/abc.2015.1050
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease2010 · 52 citations
  2. 2Advances in diagnosis of von Willebrand disease2019 · 2 citations
  3. 3von Willebrand Factor Collagen-Binding (Activity) Assay in the Diagnosis of von Willebrand Disease: A 15-Year Journey2002 · 47 citations
  4. 4Does the VWF : CB Assay Help to Diagnose von Willebrand Factor Deficiency in Patients With a Bleeding Disorder of Unknown Cause?2024 · 1 citations
  5. 5Diagnosing von Willebrand Disease: A Large Reference Laboratory's Perspective2006 · 31 citations